CARE AND CHARACTERISTICS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN US CLINICAL PRACTICE

被引：0
|
作者：
Frost, Adaani
Chakinala, Murali
Frantz, Robert
Lancaster, Lisa
Nathan, Steven
Oudiz, Ronald
Dee, Anne
Milligan, Scott
Narayan, Veena
Panjabi, Sumeet
Farber, Harrison
机构：
来源：
CHEST | 2021年 / 160卷 / 04期
关键词：
D O I：
10.1016/j.chest.2021.07.1999
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2287A / 2289A
页数：3
相关论文
共 50 条
  • [1] The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
    Sikirica, Mirko
    Iorga, Serban R.
    Bancroft, Tim
    Potash, Jesse
    [J]. BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [2] The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
    Mirko Sikirica
    Serban R Iorga
    Tim Bancroft
    Jesse Potash
    [J]. BMC Health Services Research, 14
  • [3] TRANSTHORACIC ECHOCARDIOGRAM (ECHO) AND RIGHT HEART CATHETERIZATION (RHC) AS DISEASE MANAGEMENT TOOLS FOR PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) IN US CLINICAL PRACTICE
    Chakinala, Murali
    Frantz, Robert
    Frost, Adaani
    Lancaster, Lisa
    Nathan, Steven
    Oudiz, Ronald
    Dee, Anne
    Narayan, Veena
    Panjabi, Sumeet
    Wick, Nicole
    Farber, Harrison
    [J]. CHEST, 2021, 160 (04) : 2331A - 2333A
  • [4] Epidemiological and Clinical aspects of pulmonary arterial hypertension (PAH)
    Yahiaoui, Rachida
    Bennoui, Zakia
    Hakem, Djenette
    Amrane, Rabah
    Boughrarou, Rafika
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [5] Survival in Pulmonary Arterial Hypertension (PAH) for 669 Patients Treated with Selexipag in Clinical Practice: Insights from EXPOSURE
    Soderberg, S.
    Subias, P. Escribano
    O'Donovan, C.
    Muller, A.
    Fontana, M.
    Lange, T. J.
    Gaine, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S85 - S85
  • [6] Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH).
    Badesch, D
    Galie, N
    Langleben, D
    Naeije, R
    Simonneau, G
    Barst, RJ
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S167 - S167
  • [7] Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients
    Hamilton, Neil
    Sellars, Michaela
    Graves, Mark
    Armstrong, Iain
    Charalampopolous, Athanasios
    Kiely, David
    Elliot, Charlie
    Condliffe, Robin
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [8] Development of a Comprehensive, Integrated Patient Data Repository of US Pulmonary Arterial Hypertension (PAH) Patients to Assess the Impact of Clinical Care on Patient Outcomes
    Farber, H. W.
    Milligan, S.
    Panjabi, S.
    Tsang, Y.
    Bettencourt, K.
    Cho, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] Clinical Implications of Frailty in Pulmonary Arterial Hypertension (PAH) Patients Initiated on Pharmacotherapy
    Sharif, N.
    Granton, J. T.
    Lokhandwala, A.
    Moric, J.
    Man, H.
    de Perrot, M.
    Singer, L. G.
    Rozenberg, D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [10] Treatment and survival in patients with pulmonary arterial hypertension (PAH)
    Kremers, Hilal Maradit
    Slusser, Joshua P.
    Scott, Christopher G.
    Primatesta, Paola
    McGoon, Michael D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S25 - S25
12345